Tag: Impoyz

Impoyz cream, containing clobetasol propionate, was FDA approved on November 28, 2017, for moderate to severe plaque psoriasis in adults. Its unique formulation allows for effectiveness at a lower clobetasol concentration.

Impoyz is a proprietary formulation of clobetasol propionate approved by the FDA in 2017, and while its active ingredient is widely available generically, the question of 'Is there a generic for Impoyz?' has a specific answer due to its unique formulation. Its lower concentration of clobetasol, delivered with specialized solvent technology, differentiates it from other available versions of the same drug.

Topical corticosteroids are categorized by potency, with Impoyz belonging to the 'super potent' class used for severe skin inflammation. When considering what is equivalent to Impoyz, patients and clinicians look at its generic formulation, clobetasol propionate, as well as other strong steroid treatments and alternatives.